Advanced genetic engineering of hematopoiesis
- 5 Anni 2016/2021
- 1.030.173€ Totale Fondi
Descrizione non disponibile
Pubblicazioni Scientifiche
- CELL
Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells
- CELL STEM CELL
Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells
- CELL STEM CELL
In Vivo Selection for Gene-Corrected HSPCs Advances Gene Therapy for a Rare Stem Cell Disease
- EMBO MOLECULAR MEDICINE
Genome editing for scalable production of alloantigen-free lentiviral vectors for in vivo gene therapy
- EMBO MOLECULAR MEDICINE
Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives
- NATURE BIOTECHNOLOGY
Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking
- NATURE PROTOCOLS
BAR-Seq clonal tracking of gene-edited cells
- SCIENCE TRANSLATIONAL MEDICINE
Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency